Strs Ohio Reduces Stock Holdings in CorVel Co. (NASDAQ:CRVL)

Strs Ohio lowered its stake in shares of CorVel Co. (NASDAQ:CRVL) by 11.4% during the 4th quarter, HoldingsChannel.com reports. The firm owned 3,900 shares of the business services provider’s stock after selling 500 shares during the quarter. Strs Ohio’s holdings in CorVel were worth $964,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of CRVL. Trexquant Investment LP grew its holdings in CorVel by 34.1% during the 3rd quarter. Trexquant Investment LP now owns 1,426 shares of the business services provider’s stock valued at $280,000 after purchasing an additional 363 shares during the last quarter. B. Riley Wealth Advisors Inc. grew its holdings in CorVel by 17.1% during the 3rd quarter. B. Riley Wealth Advisors Inc. now owns 1,426 shares of the business services provider’s stock valued at $280,000 after purchasing an additional 208 shares during the last quarter. Linden Thomas Advisory Services LLC grew its holdings in CorVel by 14.7% during the 3rd quarter. Linden Thomas Advisory Services LLC now owns 1,485 shares of the business services provider’s stock valued at $292,000 after purchasing an additional 190 shares during the last quarter. SkyOak Wealth LLC bought a new position in CorVel during the 4th quarter valued at about $325,000. Finally, Revisor Wealth Management LLC bought a new position in CorVel during the 3rd quarter valued at about $366,000. 51.36% of the stock is currently owned by institutional investors.

CorVel Price Performance

Shares of CRVL stock opened at $240.08 on Wednesday. The company has a market capitalization of $4.11 billion, a P/E ratio of 55.57 and a beta of 1.07. The company’s 50-day simple moving average is $244.88 and its two-hundred day simple moving average is $229.94. CorVel Co. has a one year low of $187.92 and a one year high of $265.14.

CorVel (NASDAQ:CRVL) last posted its earnings results on Tuesday, January 30th. The business services provider reported $0.99 EPS for the quarter. CorVel had a net margin of 9.69% and a return on equity of 34.66%. The company had revenue of $202.30 million during the quarter.

Insider Activity at CorVel

In related news, Director Jean Macino sold 3,130 shares of the stock in a transaction that occurred on Thursday, February 22nd. The shares were sold at an average price of $253.42, for a total transaction of $793,204.60. Following the completion of the sale, the director now owns 14,160 shares of the company’s stock, valued at $3,588,427.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other CorVel news, Chairman V Gordon Clemons sold 1,000 shares of the company’s stock in a transaction that occurred on Wednesday, February 21st. The shares were sold at an average price of $264.00, for a total transaction of $264,000.00. Following the transaction, the chairman now owns 310,534 shares in the company, valued at approximately $81,980,976. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Jean Macino sold 3,130 shares of the company’s stock in a transaction that occurred on Thursday, February 22nd. The shares were sold at an average price of $253.42, for a total transaction of $793,204.60. Following the transaction, the director now owns 14,160 shares in the company, valued at approximately $3,588,427.20. The disclosure for this sale can be found here. Insiders sold 16,043 shares of company stock valued at $3,960,007 over the last 90 days. Insiders own 48.71% of the company’s stock.

Analyst Ratings Changes

Separately, StockNews.com downgraded shares of CorVel from a “buy” rating to a “hold” rating in a research note on Saturday, March 16th.

CorVel Company Profile

CorVel Corporation provides workers' compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs.